These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19794315)

  • 1. Allopurinol, xanthine oxidase, and cardiac ischemia.
    Lee BE; Toledo AH; Anaya-Prado R; Roach RR; Toledo-Pereyra LH
    J Investig Med; 2009 Dec; 57(8):902-9. PubMed ID: 19794315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes.
    Kang SM; Lim S; Song H; Chang W; Lee S; Bae SM; Chung JH; Lee H; Kim HG; Yoon DH; Kim TW; Jang Y; Sung JM; Chung NS; Hwang KC
    Eur J Pharmacol; 2006 Mar; 535(1-3):212-9. PubMed ID: 16516885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthine oxidase inhibition alleviates the cardiac complications of insulin resistance: effect on low grade inflammation and the angiotensin system.
    El-Bassossy HM; Watson ML
    J Transl Med; 2015 Mar; 13():82. PubMed ID: 25889404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in post-ischemic heart.
    Duda M; Konior A; Klemenska E; Beresewicz A
    J Mol Cell Cardiol; 2007 Feb; 42(2):400-10. PubMed ID: 17156794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
    Doehner W; Schoene N; Rauchhaus M; Leyva-Leon F; Pavitt DV; Reaveley DA; Schuler G; Coats AJ; Anker SD; Hambrecht R
    Circulation; 2002 Jun; 105(22):2619-24. PubMed ID: 12045167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment.
    Zhao L; Roche BM; Wessale JL; Kijtawornrat A; Lolly JL; Shemanski D; Hamlin RL
    Life Sci; 2008 Feb; 82(9-10):495-502. PubMed ID: 18215719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition.
    Harzand A; Tamariz L; Hare JM
    Congest Heart Fail; 2012; 18(3):179-82. PubMed ID: 22587748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular distribution of xanthine oxidase during cardiac ischemia and reperfusion: an immunocytochemical study.
    Ashraf M; Samra ZQ
    J Submicrosc Cytol Pathol; 1993 Apr; 25(2):193-201. PubMed ID: 8324724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure.
    Mellin V; Isabelle M; Oudot A; Vergely-Vandriesse C; Monteil C; Di Meglio B; Henry JP; Dautreaux B; Rochette L; Thuillez C; Mulder P
    Eur Heart J; 2005 Aug; 26(15):1544-50. PubMed ID: 15872033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopurinol attenuates oxidative injury in rat hearts suffered ischemia/reperfusion via suppressing the xanthine oxidase/vascular peroxidase 1 pathway.
    Zhang YS; Lu LQ; Jiang YQ; Li NS; Luo XJ; Peng JW; Peng J
    Eur J Pharmacol; 2021 Oct; 908():174368. PubMed ID: 34302816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopurinol: kinetics, inhibition of xanthine oxidase activity, and protective effect in ischemic-reperfused canine heart as studied by cardiac microdialysis.
    Kuzmin AI; Tskitishvili OV; Serebryakova LI; Kapelko VI; Majorova IV; Medvedev OS
    J Cardiovasc Pharmacol; 1995 Apr; 25(4):564-71. PubMed ID: 7596124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Existence and participation of xanthine oxidase in reperfusion injury of ischemic rabbit myocardium.
    Terada LS; Rubinstein JD; Lesnefsky EJ; Horwitz LD; Leff JA; Repine JE
    Am J Physiol; 1991 Mar; 260(3 Pt 2):H805-10. PubMed ID: 2000975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol.
    Sakuma M; Toyoda S; Arikawa T; Koyabu Y; Kato T; Adachi T; Suwa H; Narita JI; Anraku K; Ishimura K; Yamauchi F; Sato Y; Inoue T;
    Clin Exp Nephrol; 2018 Dec; 22(6):1379-1386. PubMed ID: 29916098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage.
    Das DK; Engelman RM; Clement R; Otani H; Prasad MR; Rao PS
    Biochem Biophys Res Commun; 1987 Oct; 148(1):314-9. PubMed ID: 2823807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allopurinol as a therapeutic option in cardiovascular disease.
    Okafor ON; Farrington K; Gorog DA
    Pharmacol Ther; 2017 Apr; 172():139-150. PubMed ID: 27916655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.
    Pacher P; Nivorozhkin A; Szabó C
    Pharmacol Rev; 2006 Mar; 58(1):87-114. PubMed ID: 16507884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allopurinol reduces neointimal hyperplasia in the carotid artery ligation model in spontaneously hypertensive rats.
    Yamamoto Y; Ogino K; Igawa G; Matsuura T; Kaetsu Y; Sugihara S; Matsubara K; Miake J; Hamada T; Yoshida A; Igawa O; Yamamoto T; Shigemasa C; Hisatome I
    Hypertens Res; 2006 Nov; 29(11):915-21. PubMed ID: 17345792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol and xanthine oxidase inhibition in liver ischemia reperfusion.
    Peglow S; Toledo AH; Anaya-Prado R; Lopez-Neblina F; Toledo-Pereyra LH
    J Hepatobiliary Pancreat Sci; 2011 Mar; 18(2):137-46. PubMed ID: 20878424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species derived from xanthine oxidase interrupt dimerization of breast cancer resistance protein, resulting in suppression of uric acid excretion to the intestinal lumen.
    Ogura J; Kuwayama K; Sasaki S; Kaneko C; Koizumi T; Yabe K; Tsujimoto T; Takeno R; Takaya A; Kobayashi M; Yamaguchi H; Iseki K
    Biochem Pharmacol; 2015 Sep; 97(1):89-98. PubMed ID: 26119820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice.
    Nishikawa T; Nagata N; Shimakami T; Shirakura T; Matsui C; Ni Y; Zhuge F; Xu L; Chen G; Nagashimada M; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S; Ota T
    Sci Rep; 2020 Jan; 10(1):815. PubMed ID: 31965018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.